Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Shareholder disclosure by Radforsk Investeringsstiftelse

Reference is made to the stock exchange notice of 4 November 2021 by Targovax ASA ("Targovax") announcing a fully underwritten rights issue of gross proceeds NOK 175 million (the "Rights Issue"), where each existing shareholder as of 25 November 2021 (and being registered as such in the Norwegian Central Securities Depository as at the expiry of 29 November 2021 (the record date)) were granted 1.175114 subscription rights for each share registered as held by the shareholder. Each subscription right gives the right to subscribe for one new share in Targovax. The subscription period

Positive topline results reported for the Phase II COVID-19 clinical trial with the ABNCoV2 vaccine

Hørsholm, Denmark, December 5, 2021 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces that the ABNCoV2 vaccine demonstrated a strong boosting effect in the clinical Phase II trial conducted by Bavarian Nordic. The existing levels of SARS-CoV-2 neutralizing antibodies increased by 2-40-fold, depending on the initial levels of antibodies, with no serious adverse events reported. Furthermore, this strong increase was observed to be similar for all variants tested (Wuhan, Alpha, Beta and Delta). The topline results confirm the vaccine’s excellent

Isofol Medical AB (publ) invites to an audiocast on December 6 at 08.00 a.m. CET

GOTHENBURG, Sweden, December 5, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced on December 3 that the ongoing phase III study AGENT will not reach 300 PFS events with current censoring rules based on FDA decision. Following this announcement, Isofol invites investors, analysts, and media to an audiocast (in English) with a Q&A-session on December 6, at 08:00 a.m. CET.The presentation will be held by Isofol's CEO Ulf Jungnelius and CMO Roger Tell in English and will conclude with a Q&A session. Questions can be asked on the telephone conference or in written form

Another great legend awarded the world's most prestigious conservation prize

The Perfect World Award has previously been presented to legends such as Sir David Attenborough, Dr Jane Goodall, Miss Greta Thunberg, and Dr Sylvia Earl. This year, a new icon is Awarded The Perfect World Award “The Conservationist of the Year” – Dr Dian Fossey.The Perfect World Foundation recognises a person who has made significant contributions to the conservation of our natural world with the annual Nordic Wildlife Conservation Award – The Perfect World Award.  This year´s The Perfect World Award “The Conservationist of the Year” goes to Dr Dian Fossey in recognition of her ground-

Nordea Bank Abp: Repurchase of own shares on 03.12.2021

Nordea Bank AbpStock exchange release – Changes in company’s own shares03.12.2021 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 03.12.2021 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 381,648 10.47 3,996,475.61XHEL 322,362 10.50 3,385,187.83CEUX 324,427 10.49 3,404,156.82AQEU 55,443 10.47

Isofol Medical AB (publ) will not reach 300 PFS events in the AGENT study with current censoring rules based on FDA decision

GOTHENBURG, Sweden, December 3, 2021 – Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the U.S. Food and Drug Administration (FDA) denied a request from the company to adjust the analysis of the pivotal AGENT study’s secondary endpoint of progression-free survival (PFS). However, the decision will not affect the study’s primary endpoint, objective response rate, previously agreed upon with the FDA. The secondary endpoint may have to be somewhat modified.In the AGENT study, more patients than expected have proceeded to other treatments before they reached tumor

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 03.12.2021

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION 03.12.2021 at 18:30 EET ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 03.12.2021 Date 03.12.2021Exchange transaction BuyShare class ALEXAmount 401Average price/share 8.0600 EURHighest price/share 8.0600 EURLowest price/share 8.0600 EURTotal price 3,232.06 EUR The shares held by Alexandria Pankkiiriliike Oyj on 03.12.2021: ALEX 41,926 On behalf of Alexandria Pankkiiriliike Oyj  Skandinaviska Enskilda Banken AB (Publ)

Fully subscribed IPO of shares in BPC Instruments AB

LUND, SWEDEN – 3 DECEMBER 2021: On December 1, 2021, the subscription period in BPC Instruments AB (“BPC Instruments” or “the Company”) issue of shares before listing on the Spotlight Stock Market (“Spotlight”) ended. The issue was subscribed to approximately 101 percent, and the Company will thus receive the full amount of approximately SEK 15 million before issue costs amounting to approximately SEK 1.4 million. Through the issue, the Company obtains approximately 400 new shareholders. The first day of trading in BPC Instruments on Spotlight is expected to be December 16, 2021. Sedermera

Terveystalo Plc: SHARE REPURCHASE 3.12.2021

Terveystalo Plc ANNOUNCEMENT  3.12.2021 Terveystalo Plc: SHARE REPURCHASE 3.12.2021 In the Helsinki Stock Exchange Trade date           3.12.2021Bourse trade         BuyShare                  TTALOAmount             28 000 SharesAverage price/ share    10,7713 EURTotal cost            301 596,40 EUR Terveystalo Plc now holds a total of 1 315 534 sharesincluding the shares repurchased on 3.12.2021 On behalf of Terveystalo Plc Nordea Bank Oyj Janne

MPC Container Ships ASA – Call option notice from company's wholly owned subsidiary MPC Container Ships Invest B.V.

Oslo, 3 December 2021 MPC Container Ships Invest B.V. - Notice of exercise of call option MPC Container Ships Invest B.V., a wholly-owned subsidiary of MPC Container Ships ASA (the "Company"), has today notified Nordic Trustee AS of its exercise of the call option for the outstanding bonds in the bond issue MPCBV01, MPC Container Ships Invest B.V. USD 200,000,000 FRN Senior Secured Bond Issue 2017/2023 – ISIN NO0010805872, with original maturity date 22 March 2023. The outstanding bonds will be repaid in full at 102.00% of the Nominal Amount (plus accrued and unpaid interests on

MPCBV01 - Key information relating to full redemption of bond loan

Issuer:                                     MPC CONTAINER SHIPS INVEST B.V. ISIN for bond loan:                   NO0010805872 Original maturity date:             22 March 2023 New maturity date:                  17 December 2021 Redemption price:                    102.00% This information is published in accordance with the requirements of the Continuing Obligations. _________________________________________________________________________________ Notice of exercise of call option MPC Container Ships Invest B.V. (the "Company") has today notified Nordic Trustee AS (

Wallenstam sells in Tyresö

Wallenstam has today signed an agreement to sell two residential properties in Tyresö for an agreed property value of just over SEK 1 billion.“Wallenstam has 2,200 apartments in production and this number is expected to increase during next year. We now had the opportunity to divest both of these properties and thereby release resources for additional new construction. The transaction adds a significant amount to equity,” says Hans Wallenstam, CEO. The property Tyresö Järnet 12, address Axel Wennergrens väg 1/Bollmora gårdsväg 20-24, with 54 apartments, comprises about 2,400 sq m of

#21-401 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-400 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Update on regulatory approvals relating to the voluntary tender offer for Sbanken ASA – Appeal of NCA decision and extension of the Drop Dead Date

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL Oslo, 3 December 2021 Reference is made to the offer document dated 23 April 2021 (the "Offer Document") and subsequent stock exchange announcements, including 24 May 2021 (extension of the Offer Period until 7 June 2021), 7 June 2021 (final extension of Offer Period until 14 June 2021, reduction of minimum acceptance condition to 2/3 and

Lifco acquires Truck-line GmbH in Germany

Lifco  has signed an agreement to acquire a majority of the shares in Truck-line GmbH . The company is a leading manufacturer of high-end lightbars for trucks, sold under the LightFix brand. Truck-line has 31 employees and reported net sales of approximately MEUR 15 in 2020. The company is based in Ahrensburg, Germany. Truck-line will be consolidated in Business Area Systems Solutions, division Service and Distribution. Consolidation is expected to take place in December, 2021. The acquisition will not have any significant effect on Lifco’s

Asetek - Share Capital Increase Upon Exercise of Warrants

Reference is made to warrants issued by Asetek A/S, Danish central business register (CVR) no. 34880522 (the "Company"), pursuant to corporate resolutions adopted on August 11, 2015 and April 28, 2016 respectively. Pursuant to the applicable warrant terms, the warrants are exercisable in exercise windows open in a four weeks period running from the Company's preliminary announcement of its financial statements or publication of its interim financial report however no later than 7 years after the Subscription Date as specified in the Subscription Agreement, at 12 noon. Each warrant

Lifco acquires Easy Life International B.V. in the Netherlands

Lifco  has signed an agreement to acquire a majority of the shares in Easy Life International B.V . The company is a manufacturer of consumables used for water purification and plant nutrition for aquariums. Easy Life has six employees and reported net sales of approximately MEUR 3.3 in 2020. The company is based in Duiven in the Netherlands. Easy Life will be consolidated in Business Area Systems Solutions, division Environmental Technology. Consolidation is expected to take place in December, 2021. The acquisition will not have any

Self Storage Group ASA - Acquisition of new property in Kristiansand, Norway

(Oslo, 3 December 2021) Self Storage Group ASA (Self Storage Group, OSE:SSG) has entered into an agreement to acquire a property in Kartheia 5 in Kristiansand, Norway. The transaction has a value of NOK 4.3 million. The property has a potential lettable area of 550 square meters. The facility is projected to open in Q2 2022 and will be operated under the OK Minilager brand. "The property is located in Kartheia, close to the city center of Kristiansand. With this investment we will strengthen our number one position in Kristiansand, Norway´s 5[th] largest city. The location is a great

CS MEDICA A/S: Danish Parliament voted yes for a permanent scheme for medical cannabis in Denmark

CS MEDICA A/S (”CS MEDICA” or the ”Company”) hereby announces that the Danish Parliament has voted unanimously, to make the current Pilot Programme for medical cannabis a permanent scheme. Companies’ opportunities to produce medical cannabis become permanent, while doctors' ability to prescribe cannabis drugs is extended by four years.The Danish Parliament voted unanimously, 102-0, to make the current pilot program for medical cannabis a permanent scheme. In doing so, companies will be able to manufacture cannabis for medical use on a permanent basis. In addition, doctors are now able to

Basware Launches Partner Center of Excellence to Enable World-Class Partner Implementations

Emphasizes Collaboration and Knowledge-Sharing Between Implementation Partners and Basware Solution ArchitectsBasware  (Nasdaq: BAS1V) launches its Partner Center of Excellence (PCoE), as part of a continued focus on improving customer outcomes, to help its implementation partners boost their procure-to-pay (P2P) deliveries.   The PCoE is aimed at combining the talents of the qualified partners and Basware to improve the customer implementation experience, optimize implementation skills of partners and reduce technical risks in customer

Statement by the Board of Directors in relation to the withdrawal of the public cash offer by Advent and GIC

The Board of Directors remains fully committed to Sobi and Sobi’s strategy Håkan Björklund, Chairman of the Board of Directors: “We are as committed as ever to helping people with rare diseases. The Board and I have confidence in Sobi’s vision: To be recognised as a global leader in rare diseases. We have taken important steps towards this vision in recent years, and we are proud of the clear progress made. We have a strong belief in Sobi’s strategy and the opportunities ahead. Sobi’s strategy is clear, and we are confident that the company will continue to focus and deliver on the

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                                                        Samppa RönkäPosition:                                                    CTO Notification type:                                       Initial notificationIssuer Name:                                              Nitro Games OyjLEI:                                                           743700XPEJZPMWDULF59Transaction detailsTransaction date:                                        2021-12-03 Venue:                                                       First North

Nitro Games Oyj: Managers’ Transactions

Person subject to the notification requirementName:                                                        Matti NikkolaPosition:                                                    CFO Notification type:                                       Initial notificationIssuer Name:                                              Nitro Games OyjLEI:                                                           743700XPEJZPMWDULF59Transaction detailsTransaction date:                                        2021-12-03 Venue:                                                       First North

There are no items matching the current filter
There are no more items matching the current filter
Back to top